A Novel Immunostimulatory Polymer Conjugate to Enhance the Efficacy of Radiotherapy in the Treatment of Pancreatic Ductal Adenocarcinoma.” Hafeli U, Esposito T, Saatchi K. $150,000. Blueline Biosciences Inc (2015-2016).
“Development of Second Generation Radioembolizing Microspheres” (2015) Biomaterials Day, University of Washington, Seattle, USA
“Radiopharmaceuticals and Drug Delivery Systems as Nanomedicines” (2013) International Symposium of Applied Bioinorganic Chemistry-ISABC12, Guangzhou, China
“Metal Coordinated Nano-Sized Macromolecules for Intravascular and Organ-Specific Diagnoses” (2012) International Conference of Coordination Chemistry-ICCC40, Valencia, Spain
“Heparin Functionalized Magnetic Nanoparticles to Investigate Diabetic Heart Lipotoxicity” (2008) Magnetic Nanostructures, Gordon Research Conference, Aussois, France
“Synthesis of Biodegradable Metal-Specific Polymers” (2007) Polymers in Medicine and Biology, American Chemical Society, Santa Rosa, USA
Dr. Saatchi completed a Bachelor of Sciences in Chemistry (Tehran, Iran) and a Doctor of Philosophy in Medicinal Inorganic Chemistry at the University of British Columbia. Dr. Saatchi is a Senior Research Associate in the Faculty of Pharmaceutical Sciences UBC.
Dr. Saatchi is the course coordinator and instructor for Phar 525. She also teaches sections of Phar 510, Phar 515 and Phar 518.
The research focus of Dr. Saatchi is the syntheses and modification of small and macro (bio)molecules (polymers, peptides, proteins, etc.) and their alteration with radioisotopes, fluorescent molecules and other diagnostic probes for imaging or cancer therapy. These novel formulations are then used for drug delivery and as radiopharmaceuticals for imaging (SPECT, PET, CT) or as theranostics.